Developer docs
API playgroundTry for free, no card

Search company profiles

Fette Pharma GmbH

Full company profile

uuid004f284

Namestring
Fette Pharma GmbH
Legal namestring
Fette Pharma GmbH
Websiteurl
fette-pharma.de
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Fette Pharma GmbH is a privately-held German pharmaceutical services company headquartered in Egelsbach, Germany, with a secondary operations facility in Nordhorn. The company operates as a licensed distributor and gateway for medical cannabis products into the German market, which it describes as the largest medicinal cannabis market in Europe. It holds GDP and EU-GMP certifications, which are the regulatory prerequisites for handling and distributing medical cannabis products in Germany.

The company provides an integrated service offering to international cannabis cultivators and brands seeking to enter the German market: local distribution and last-mile logistics to pharmacies, integrated supply chain management spanning GACP cultivation support through EU-GMP market introduction, and brand-building services. Its distribution model is direct-to-pharmacy, bypassing brokers and consultants, which is the primary differentiator versus competitors. The company also operates the RE:CANNIS sub-brand, positioned as a proprietary medical cannabis therapy brand in the German market.

The business model is B2B and sales-led, with revenue generated through transaction fees on direct sales and logistics services, managed services for integrated supply chain support, and professional services for brand development. The company is small, with 8 employees, and is led by two Managing Directors (Geschäftsführer): Maik Dobiey and Jörg Löser. No revenue, funding, or transaction volume is publicly disclosed. The company has no proprietary technology platform, no API, no disclosed AI capabilities, and no patents or trademarks. Its sole disclosed external partnership is a web hosting relationship with INSIGMA IT Engineering GmbH.

Short descriptiontext

Fette Pharma GmbH is a German pharmaceutical distribution company (8 employees, Egelsbach) that provides direct, GDP- and EU-GMP-certified distribution and supply chain services for international cannabis cultivators and brands seeking to enter the German medical cannabis market.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEgelsbach, Germany
HQ citystring
Egelsbach
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis distribution, pharmaceutical logistics services, EU-GMP certification, pharmacy supply chain, cannabis market entry
Industry1 code
PRIMARYCRAOAIAF
Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Direct Sales & Logistics Services
TypeTransaction Fee
Description

Local distribution, customer care, and last-mile delivery in Germany for medical cannabis products.

fette-pharma.de
2Integrated Supply Chain Services
TypeManaged Services
Description

Comprehensive services from GACP cultivation through EU-GMP market introduction, supporting partners entering the German medical cannabis market.

fette-pharma.de
3Brand Building Services
TypeProfessional Services
Description

Establishment and development of proprietary brands within the German medical cannabis market, the largest medicinal market in Europe.

fette-pharma.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1RE:CANNIS
Description

The new standard in medical cannabis therapy. A brand offering associated with Fette Pharma for medical cannabis products in the German market.

fette-pharma.de
Core offering1 text field

Fette Pharma GmbH is a licensed, GDP- and GMP-certified distribution and service provider for medical cannabis in Germany. It offers direct sales, local distribution, customer care, and last-mile delivery to the German pharmacy network, alongside integrated supply chain support from GACP cultivation through EU-GMP market introduction, and brand building services for partner brands seeking to enter the German market. Operating brands include the RE:CANNIS sub-brand, positioned as a new standard in medical cannabis therapy.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Fette Pharma GmbH operates as a licensed distribution company for the German medical cannabis market, providing integrated services including direct sales and logistics, supply chain management from GACP cultivation to EU-GMP certification, brand development support, and direct market access without broker fees. The company distributes products under its own operational umbrella as well as through the RE:CANNIS sub-brand, which represents a medical cannabis therapy brand positioned as a new standard in the market.

Product and service2 records
1Cannabis Distribution Services
CategoryPharmaceutical distribution and logistics
Description

Distribution and logistics services for medical cannabis products in the German market, including direct sales, local distribution, customer support, and last-mile delivery within Germany. Service scope spans GACP cultivation support through EU-GMP market introduction, designed for licensed cannabis cultivators and brands seeking to enter the German pharmacy channel.

2RE:CANNIS
CategoryMedical cannabis brand
Description

Sub-brand of Fette Pharma positioned as the new standard in medical cannabis therapy, offered through the Fette Pharma distribution network in the German market for patient dispensing.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RE:CANNIS is a brand under Fette Pharma representing the new standard in medical cannabis therapy. It is positioned as a key product/brand offering in the company's portfolio for the German medical cannabis market.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Berlin-based cannabis company spanning medical and consumer segments, with distribution and brand activities in Germany. Broader incumbent operating across multiple cannabis verticals.

TypeDirect peer
Description

Cologne-based medical cannabis wholesaler serving German pharmacies with EU-GMP product. Direct competitor on the wholesale-distribution-to-pharmacy model.

TypeDirect peer
Description

German medical cannabis distributor/brand owner supplying pharmacies across Germany. Comparable as a domestic peer combining distribution and own-brand activity in the same regulated channel.

TypeBroad incumbent
Description

Vertically integrated German medical cannabis cultivator and distributor. Comparable as a domestic player covering cultivation-to-pharmacy flow, but operates its own cultivation rather than being purely distribution-led.

TypeDirect peer
Description

German medical cannabis wholesale distributor operating a direct-to-pharmacy platform. Directly comparable to Fette Pharma on customer (pharmacies), product (medical cannabis), and B2B distribution model in Germany.

6avaay GmbH
TypeEmerging player
Description

German medical cannabis brand/distributor combining own-brand and B2B supply to pharmacies. Comparable as a younger peer also pairing brand-building with pharmacy-channel distribution.

TypeBroad incumbent
Description

European arm of a major Canadian cannabis producer with German market presence and EU-GMP supply. Comparable as a large upstream supplier/cultivator whose products can flow through Fette Pharma's distribution channel.

TypeDirect peer
Description

German medical cannabis wholesale distributor serving pharmacies. Direct competitor on regulatory-certified B2B distribution into the German pharmacy network.

TypeOthers
Description

German manufacturer of medically certified vaporizers used in cannabis therapy. Adjacent to Fette Pharma's end-market (medical cannabis patients) but operates in devices rather than distribution.

TypeDirect peer
Description

German medical cannabis distributor with pharmacy delivery network. Comparable as a domestic cannabis wholesaler targeting the same regulated pharmacy channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fette Pharma GmbH

Pharmaceutical Distribution Servicesfette-pharma.de

Fette Pharma GmbH is a German pharmaceutical distribution company (8 employees, Egelsbach) that provides direct, GDP- and EU-GMP-certified distribution and supply chain services for international cannabis cultivators and brands seeking to enter the German medical cannabis market.

What Fette Pharma GmbH does

Fette Pharma GmbH is a privately-held German pharmaceutical services company headquartered in Egelsbach, Germany, with a secondary operations facility in Nordhorn. The company operates as a licensed distributor and gateway for medical cannabis products into the German market, which it describes as the largest medicinal cannabis market in Europe. It holds GDP and EU-GMP certifications, which are the regulatory prerequisites for handling and distributing medical cannabis products in Germany.

The company provides an integrated service offering to international cannabis cultivators and brands seeking to enter the German market: local distribution and last-mile logistics to pharmacies, integrated supply chain management spanning GACP cultivation support through EU-GMP market introduction, and brand-building services. Its distribution model is direct-to-pharmacy, bypassing brokers and consultants, which is the primary differentiator versus competitors. The company also operates the RE:CANNIS sub-brand, positioned as a proprietary medical cannabis therapy brand in the German market.

The business model is B2B and sales-led, with revenue generated through transaction fees on direct sales and logistics services, managed services for integrated supply chain support, and professional services for brand development. The company is small, with 8 employees, and is led by two Managing Directors (Geschäftsführer): Maik Dobiey and Jörg Löser. No revenue, funding, or transaction volume is publicly disclosed. The company has no proprietary technology platform, no API, no disclosed AI capabilities, and no patents or trademarks. Its sole disclosed external partnership is a web hosting relationship with INSIGMA IT Engineering GmbH.

Fette Pharma GmbH firmographics

Firmographics
Name
Fette Pharma GmbH
Legal name
Fette Pharma GmbH
Website
https://fette-pharma.de
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Fette Pharma GmbH is a German pharmaceutical distribution company (8 employees, Egelsbach) that provides direct, GDP- and EU-GMP-certified distribution and supply chain services for international cannabis cultivators and brands seeking to enter the German medical cannabis market.
Ownership category
akta.pro rank

Fette Pharma GmbH industry classification

Industry
Product category
Pharmaceutical Distribution Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRAOAIAF
Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
Consumer Products & Retail/Wholesale, Distribution & Category Management/Alcohol, Tobacco & Cannabis Wholesale Distribution

Keywords

  • Medical cannabis distribution
  • Pharmaceutical logistics services
  • EU-GMP certification
  • Pharmacy supply chain
  • Cannabis market entry

Where Fette Pharma GmbH is headquartered

Location

Headquarters

HQ city
Egelsbach
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Fette Pharma GmbH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Direct Sales & Logistics Services: Local distribution, customer care, and last-mile delivery in Germany for medical cannabis products.
  2. Integrated Supply Chain Services: Comprehensive services from GACP cultivation through EU-GMP market introduction, supporting partners entering the German medical cannabis market.
  3. Brand Building Services: Establishment and development of proprietary brands within the German medical cannabis market, the largest medicinal market in Europe.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Fette Pharma GmbH product offering

Product offering

Core offering

Fette Pharma GmbH is a licensed, GDP- and GMP-certified distribution and service provider for medical cannabis in Germany. It offers direct sales, local distribution, customer care, and last-mile delivery to the German pharmacy network, alongside integrated supply chain support from GACP cultivation through EU-GMP market introduction, and brand building services for partner brands seeking to enter the German market. Operating brands include the RE:CANNIS sub-brand, positioned as a new standard in medical cannabis therapy.

Product overview

Fette Pharma GmbH operates as a licensed distribution company for the German medical cannabis market, providing integrated services including direct sales and logistics, supply chain management from GACP cultivation to EU-GMP certification, brand development support, and direct market access without broker fees. The company distributes products under its own operational umbrella as well as through the RE:CANNIS sub-brand, which represents a medical cannabis therapy brand positioned as a new standard in the market.

Differentiator

Problem solved

Functional benefit

Brands

  • RE:CANNIS: The new standard in medical cannabis therapy. A brand offering associated with Fette Pharma for medical cannabis products in the German market.

Products and services

  • Cannabis Distribution Services Distribution and logistics services for medical cannabis products in the German market, including direct sales, local distribution, customer support, and last-mile delivery within Germany. Service scope spans GACP cultivation support through EU-GMP market introduction, designed for licensed cannabis cultivators and brands seeking to enter the German pharmacy channel.
  • RE:CANNIS Sub-brand of Fette Pharma positioned as the new standard in medical cannabis therapy, offered through the Fette Pharma distribution network in the German market for patient dispensing.

Companies that use Fette Pharma GmbH

Customer profile

Segments3 records

Ideal customer profiles3 records

Fette Pharma GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Fette Pharma GmbH partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • RE:CANNIScoreStrategic or Co-development PartnerRE:CANNIS is a brand under Fette Pharma representing the new standard in medical cannabis therapy. It is positioned as a key product/brand offering in the company's portfolio for the German medical cannabis market.

Scale indicators1 record

Recent moves6 records

Expansion highlights3 records

Fette Pharma GmbH competitors and assessment

Company assessment

Broad incumbents

  • Sanity Group GmbH: Berlin-based cannabis company spanning medical and consumer segments, with distribution and brand activities in Germany. Broader incumbent operating across multiple cannabis verticals.
  • Demecan GmbH: Vertically integrated German medical cannabis cultivator and distributor. Comparable as a domestic player covering cultivation-to-pharmacy flow, but operates its own cultivation rather than being purely distribution-led.
  • Aurora Europe GmbH (Aurora Cannabis): European arm of a major Canadian cannabis producer with German market presence and EU-GMP supply. Comparable as a large upstream supplier/cultivator whose products can flow through Fette Pharma's distribution channel.

Direct peers

  • Cannamedical Pharma GmbH: Cologne-based medical cannabis wholesaler serving German pharmacies with EU-GMP product. Direct competitor on the wholesale-distribution-to-pharmacy model.
  • Four 20 Pharma GmbH: German medical cannabis distributor/brand owner supplying pharmacies across Germany. Comparable as a domestic peer combining distribution and own-brand activity in the same regulated channel.
  • Cansativa GmbH: German medical cannabis wholesale distributor operating a direct-to-pharmacy platform. Directly comparable to Fette Pharma on customer (pharmacies), product (medical cannabis), and B2B distribution model in Germany.
  • Lexamed GmbH: German medical cannabis wholesale distributor serving pharmacies. Direct competitor on regulatory-certified B2B distribution into the German pharmacy network.
  • Nimbus Health GmbH: German medical cannabis distributor with pharmacy delivery network. Comparable as a domestic cannabis wholesaler targeting the same regulated pharmacy channel.

Emerging players

  • avaay GmbH: German medical cannabis brand/distributor combining own-brand and B2B supply to pharmacies. Comparable as a younger peer also pairing brand-building with pharmacy-channel distribution.

Others

  • Storz & Bickel GmbH: German manufacturer of medically certified vaporizers used in cannabis therapy. Adjacent to Fette Pharma's end-market (medical cannabis patients) but operates in devices rather than distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

Fette Pharma GmbH social profiles

Digital presence

Fette Pharma GmbH compliance and trust

Trust signal

Compliance2 records

Fette Pharma GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fette Pharma GmbH leadership team

Management profile

Number of profiles

Profiles2 records

Fette Pharma GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fette Pharma GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fette Pharma GmbH

What does Fette Pharma GmbH do?

Fette Pharma GmbH is a licensed, GDP- and GMP-certified distribution and service provider for medical cannabis in Germany. It offers direct sales, local distribution, customer care, and last-mile delivery to the German pharmacy network, alongside integrated supply chain support from GACP cultivation through EU-GMP market introduction, and brand building services for partner brands seeking to enter the German market. Operating brands include the RE:CANNIS sub-brand, positioned as a new standard in medical cannabis therapy.

Is Fette Pharma GmbH a public or private company?

Fette Pharma GmbH is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Fette Pharma GmbH founded?

Fette Pharma GmbH was founded in -1. It employs 1 to 10 people.

Where is Fette Pharma GmbH based?

Fette Pharma GmbH is headquartered in Egelsbach, Germany, in the Europe region.

How does Fette Pharma GmbH make money?

Three revenue lines are on record. Direct Sales & Logistics Services are the primary driver. The others are integrated Supply Chain Services and brand Building Services.

Who are Fette Pharma GmbH's main competitors?

Broad incumbents on record are Sanity Group GmbH, Demecan GmbH and Aurora Europe GmbH (Aurora Cannabis). Direct peers are Cannamedical Pharma GmbH, Four 20 Pharma GmbH, Cansativa GmbH, Lexamed GmbH and Nimbus Health GmbH. avaay GmbH is listed as an emerging player. Storz & Bickel GmbH is listed as an others.

Does Fette Pharma GmbH have an API?

No public API is recorded for Fette Pharma GmbH.

What industry is Fette Pharma GmbH in?

Fette Pharma GmbH's product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales